• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双视图联合学习提高个性化药物协同预测。

Dual-view jointly learning improves personalized drug synergy prediction.

机构信息

CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Bio-Med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Science, Shanghai 200031, China.

出版信息

Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae604.

DOI:10.1093/bioinformatics/btae604
PMID:39423102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524890/
Abstract

MOTIVATION

Accurate and robust estimation of the synergistic drug combination is important for medicine precision. Although some computational methods have been developed, some predictions are still unreliable especially for the cross-dataset predictions, due to the complex mechanism of drug combinations and heterogeneity of cancer samples.

RESULTS

We have proposed JointSyn that utilizes dual-view jointly learning to predict sample-specific effects of drug combination from drug and cell features. JointSyn outperforms existing state-of-the-art methods in predictive accuracy and robustness across various benchmarks. Each view of JointSyn captures drug synergy-related characteristics and makes complementary contributes to the final prediction of the drug combination. Moreover, JointSyn with fine-tuning improves its generalization ability to predict a novel drug combination or cancer sample using a small number of experimental measurements. We also used JointSyn to generate an estimated atlas of drug synergy for pan-cancer and explored the differential pattern among cancers. These results demonstrate the potential of JointSyn to predict drug synergy, supporting the development of personalized combinatorial therapies.

AVAILABILITY AND IMPLEMENTATION

Source code and data are available at https://github.com/LiHongCSBLab/JointSyn.

摘要

动机

准确而稳健的协同药物组合估计对于医学精准性非常重要。尽管已经开发了一些计算方法,但由于药物组合的复杂机制和癌症样本的异质性,一些预测仍然不可靠,特别是对于跨数据集的预测。

结果

我们提出了 JointSyn,它利用双视图联合学习,从药物和细胞特征中预测药物组合对特定样本的作用。在各种基准测试中,JointSyn 在预测准确性和稳健性方面均优于现有的最先进方法。JointSyn 的每个视图都捕获了与药物协同作用相关的特征,并对药物组合的最终预测做出了互补的贡献。此外,通过微调 JointSyn 可以提高其在使用少量实验测量值预测新的药物组合或癌症样本时的泛化能力。我们还使用 JointSyn 生成了泛癌的药物协同作用估计图谱,并探索了癌症之间的差异模式。这些结果表明了 JointSyn 预测药物协同作用的潜力,支持了个性化组合疗法的发展。

可用性和实现

源代码和数据可在 https://github.com/LiHongCSBLab/JointSyn 上获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/dfae3382bd8f/btae604f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/bf96f326ecf6/btae604f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/90f9bd989d61/btae604f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/316b759535ba/btae604f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/c74cc48b6c28/btae604f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/758e2094cbd5/btae604f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/dfae3382bd8f/btae604f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/bf96f326ecf6/btae604f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/90f9bd989d61/btae604f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/316b759535ba/btae604f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/c74cc48b6c28/btae604f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/758e2094cbd5/btae604f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ac/11524890/dfae3382bd8f/btae604f6.jpg

相似文献

1
Dual-view jointly learning improves personalized drug synergy prediction.双视图联合学习提高个性化药物协同预测。
Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae604.
2
In silico drug combination discovery for personalized cancer therapy.用于个性化癌症治疗的计算机辅助药物组合发现
BMC Syst Biol. 2018 Mar 19;12(Suppl 2):16. doi: 10.1186/s12918-018-0546-1.
3
Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.多向关系增强超图表示学习在抗癌药物协同作用预测中的应用。
Bioinformatics. 2022 Oct 14;38(20):4782-4789. doi: 10.1093/bioinformatics/btac579.
4
TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.TranSynergy:用于药物组合协同预测和途径解卷积的基于机制的可解释深度神经网络。
PLoS Comput Biol. 2021 Feb 12;17(2):e1008653. doi: 10.1371/journal.pcbi.1008653. eCollection 2021 Feb.
5
An integrated framework for identification of effective and synergistic anti-cancer drug combinations.一种用于识别有效和协同抗癌药物组合的综合框架。
J Bioinform Comput Biol. 2018 Oct;16(5):1850017. doi: 10.1142/S0219720018500178. Epub 2018 Jun 28.
6
Hi-GeoMVP: a hierarchical geometry-enhanced deep learning model for drug response prediction.Hi-GeoMVP:一种分层几何增强的深度学习模型,用于药物反应预测。
Bioinformatics. 2024 Mar 29;40(4). doi: 10.1093/bioinformatics/btae204.
7
Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.基于贝叶斯多视图多任务线性回归的药物反应预测特征组合的系统识别。
Bioinformatics. 2017 Jul 15;33(14):i359-i368. doi: 10.1093/bioinformatics/btx266.
8
MARSY: a multitask deep-learning framework for prediction of drug combination synergy scores.MARSY:一种用于预测药物组合协同分数的多任务深度学习框架。
Bioinformatics. 2023 Apr 3;39(4). doi: 10.1093/bioinformatics/btad177.
9
Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor.基于低秩全局注意力机制和双线性预测器的协同抗癌药物组合预测。
Bioinformatics. 2023 Oct 3;39(10). doi: 10.1093/bioinformatics/btad607.
10
Anticancer drug synergy prediction in understudied tissues using transfer learning.利用迁移学习预测研究较少的组织中的抗癌药物协同作用。
J Am Med Inform Assoc. 2021 Jan 15;28(1):42-51. doi: 10.1093/jamia/ocaa212.

本文引用的文献

1
SAFER: sub-hypergraph attention-based neural network for predicting effective responses to dose combinations.SAFER:基于子超图注意力的神经网络,用于预测对剂量组合的有效反应。
BMC Bioinformatics. 2024 Jul 30;25(1):250. doi: 10.1186/s12859-024-05873-9.
2
From cell lines to cancer patients: personalized drug synergy prediction.从细胞系到癌症患者:个性化药物协同作用预测
Bioinformatics. 2022 Jan 1;40(5). doi: 10.1093/bioinformatics/btae134.
3
MMSyn: A New Multimodal Deep Learning Framework for Enhanced Prediction of Synergistic Drug Combinations.
MMSyn:一种新的多模态深度学习框架,用于增强协同药物组合的预测。
J Chem Inf Model. 2024 May 13;64(9):3689-3705. doi: 10.1021/acs.jcim.4c00165. Epub 2024 Apr 27.
4
A visual-language foundation model for pathology image analysis using medical Twitter.一种使用医学推特进行病理学图像分析的视觉语言基础模型。
Nat Med. 2023 Sep;29(9):2307-2316. doi: 10.1038/s41591-023-02504-3. Epub 2023 Aug 17.
5
Transfer learning for drug-target interaction prediction.药物-靶标相互作用预测的迁移学习。
Bioinformatics. 2023 Jun 30;39(39 Suppl 1):i103-i110. doi: 10.1093/bioinformatics/btad234.
6
Harmonizing across datasets to improve the transferability of drug combination prediction.跨数据集协调以提高药物组合预测的可转移性。
Commun Biol. 2023 Apr 11;6(1):397. doi: 10.1038/s42003-023-04783-5.
7
DSN-DDI: an accurate and generalized framework for drug-drug interaction prediction by dual-view representation learning.DSN-DDI:一种通过双视图表示学习进行药物相互作用预测的准确且通用的框架。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac597.
8
A technical note on emerging combination approach involved in the onconanotherapeutics.关于 Oncolanotherapeutics 中涉及的新兴联合方法的技术说明。
Drug Deliv. 2022 Dec;29(1):3197-3212. doi: 10.1080/10717544.2022.2132018.
9
Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.多向关系增强超图表示学习在抗癌药物协同作用预测中的应用。
Bioinformatics. 2022 Oct 14;38(20):4782-4789. doi: 10.1093/bioinformatics/btac579.
10
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations.DTSyn:一种基于双转换器的神经网络,用于预测协同药物组合。
Brief Bioinform. 2022 Sep 20;23(5). doi: 10.1093/bib/bbac302.